Global Benign Prostatic Hyperplasia (BPH) Drugs Market Research Report 2017

Name: Global Benign Prostatic Hyperplasia (BPH) Drugs Market Research Report 2017
Brand: QYResearch
SKU: G6A1CE75B7BEN
Price: 2900 USD
Availability: InStock

September 2017 | 112 pages | ID: G6A1CE75B7BEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the global Benign Prostatic Hyperplasia (BPH) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Drugs in these regions, from 2012 to 2022 (forecast), covering

North America
Europe
China
Japan
Southeast Asia
India

Global Benign Prostatic Hyperplasia (BPH) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Advaxis
Agennix
ANI Pharmaceuticals
BHR Pharma
Bristol-Myers Squibb
Boehringer Ingelheim
Dendreo
Endo Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Alpha-blocker
Phosphodiesterase type-5 inhibitors
5-alpha-Reductase inhibitors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Drugs for each application, including

Clinical medicine
Scientific research
Others

Global Benign Prostatic Hyperplasia (BPH) Drugs Market Research Report 2017

1 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Drugs
1.2 Benign Prostatic Hyperplasia (BPH) Drugs Segment by Type (Product Category)
  1.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 Alpha-blocker
  1.2.4 Phosphodiesterase type-5 inhibitors
  1.2.5 5-alpha-Reductase inhibitors
1.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Segment by Application
  1.3.1 Benign Prostatic Hyperplasia (BPH) Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Clinical medicine
  1.3.3 Scientific research
  1.3.4 Others
1.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Market by Region (2012-2022)
  1.4.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Benign Prostatic Hyperplasia (BPH) Drugs (2012-2022)
  1.5.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Benign Prostatic Hyperplasia (BPH) Drugs Market Competitive Situation and Trends
  2.5.1 Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration Rate
  2.5.2 Benign Prostatic Hyperplasia (BPH) Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Production and Market Share by Region (2012-2017)
3.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption by Region (2012-2017)
4.2 North America Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Production and Market Share by Type (2012-2017)
5.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Price by Type (2012-2017)
5.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Production Growth by Type (2012-2017)

6 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Astellas Pharma
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Sanofi
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 ADC Therapeutics
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Advaxis
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Agennix
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Agennix Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 ANI Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 BHR Pharma
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Bristol-Myers Squibb
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Boehringer Ingelheim
7.12 Dendreo
7.13 Endo Pharmaceuticals

8 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MANUFACTURING COST ANALYSIS

8.1 Benign Prostatic Hyperplasia (BPH) Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Benign Prostatic Hyperplasia (BPH) Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET FORECAST (2017-2022)

12.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Price and Trend Forecast (2017-2022)
12.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Benign Prostatic Hyperplasia (BPH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Benign Prostatic Hyperplasia (BPH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Benign Prostatic Hyperplasia (BPH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Benign Prostatic Hyperplasia (BPH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Picture of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Alpha-blocker
Table Major Manufacturers of Alpha-blocker
Figure Product Picture of Phosphodiesterase type-5 inhibitors
Table Major Manufacturers of Phosphodiesterase type-5 inhibitors
Figure Product Picture of 5-alpha-Reductase inhibitors
Table Major Manufacturers of 5-alpha-Reductase inhibitors
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption (MT) by Applications (2012-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Market Share by Applications in 2016
Figure Clinical medicine Examples
Figure Scientific research Examples
Figure Others Examples
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD), Comparison (MT) and CAGR (%) by Regions (2012-2022)
Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT) Status and Outlook (2012-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Major Players Product Capacity (MT) (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity (MT) of Key Manufacturers (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity (MT) of Key Manufacturers in 2016
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity (MT) of Key Manufacturers in 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Major Players Product Production (MT) (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) of Key Manufacturers (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Benign Prostatic Hyperplasia (BPH) Drugs Production Share by Manufacturers
Figure 2017 Benign Prostatic Hyperplasia (BPH) Drugs Production Share by Manufacturers
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Manufacturers
Table 2017 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Manufacturers
Table Global Market Benign Prostatic Hyperplasia (BPH) Drugs Average Price (USD/Kg) of Key Manufacturers (2012-2017)
Figure Global Market Benign Prostatic Hyperplasia (BPH) Drugs Average Price (USD/Kg) of Key Manufacturers in 2016
Table Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Product Category
Figure Benign Prostatic Hyperplasia (BPH) Drugs Market Share of Top 3 Manufacturers
Figure Benign Prostatic Hyperplasia (BPH) Drugs Market Share of Top 5 Manufacturers
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity (MT) by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity Market Share by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity Market Share by Region
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share by Region
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Region
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT) and Growth Rate (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption (MT) Market by Region (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Market Share by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption (MT) Market Share by Region
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) by Type (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Price (USD/Kg) by Type (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Growth by Type (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption (MT) by Application (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Market Share by Application (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Market Share by Application in 2016
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Growth Rate by Application (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table ADC Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table Advaxis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table Agennix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agennix Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Agennix Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure Agennix Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure Agennix Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table ANI Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table BHR Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Production Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share (2012-2017)
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Benign Prostatic Hyperplasia (BPH) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2016
Table Major Buyers of Benign Prostatic Hyperplasia (BPH) Drugs
Table Distributors/Traders List
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity, Production (MT) and Growth Rate Forecast (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) Forecast by Region (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption (MT) Forecast by Region (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) Forecast by Type (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production (MT) Forecast by Type (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Price Forecast by Type (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption (MT) Forecast by Application (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption (MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Global Benign Prostatic Hyperplasia (BPH) Drugs Market Research Report 2017

More Publications

Need Help?

Ask a Question

Market Reports